ID
41732
Descripción
The primary objective of this study was to demonstrate bioequivalence between eltrombopag oral film-coated tablets manufactured at Research and Development (R&D) and Commercial sites. The subject participants each went through two dosing periods (Period 1 and Period 2), during each of which they received a single dose of eltrombopag. The dosing periods were separated by a washout of at least 10 days. For each period, subjects had to perform a visit on the day before and one on the day of the administration of the drug. Furthermore, the protocol-defined visits included a screening visit and a follow-up visit. Study ID: 105122 Clinical Study ID: 105122 Study Title: Phase I Bioequivalence Study for SB 497115 GR Phase II and Phase III Tablets Sponsor: GlaxoSmithKline Phase: phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Study Indication: Thrombocytopenia This form has to be filled out by all participants to document, whether pharmacogenetic research consent is either given, not given or withdrawn after it had been previously given.
Palabras clave
Versiones (2)
- 9/1/21 9/1/21 -
- 9/1/21 9/1/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
9 de enero de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Eltrombopag Thrombocytopenia, Clinical Study ID: 105122
Pharmacogenetic Research
- StudyEvent: ODM
Descripción
PGx-Pharmacogenetic Research Consent
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0021430
Descripción
informed consent for pharmacogenetic research
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Descripción
pharmacogenetic research consent, date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Descripción
pharmacogenetic research, blood sample
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1277698
- UMLS CUI [1,2]
- C2347500
Descripción
date blood sample taken, pharmacogenetic test
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1277698
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C2347500
Descripción
pharmacogenetic tests, no consent, reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0332197
- UMLS CUI [1,4]
- C0566251
Descripción
pharmacogenetic tests, no consent, other reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0332197
- UMLS CUI [1,4]
- C3840932
Descripción
genetics type
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0017399
- UMLS CUI [1,2]
- C0332307
Descripción
PGx-Pharmacogenetic Research Withdrawal of Consent
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0021430
- UMLS CUI-3
- C2349954
Descripción
withdrawn consent for PGx-Pharmacogenetic research
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2349954
Descripción
pharmacogenetic research, request for sample destruction
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C1272683
Descripción
pharmacogenetic research, request for sample destruction, reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C1272683
- UMLS CUI [1,4]
- C0566251
Descripción
pharmacogenetic research, request for sample destruction, other reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C1272683
- UMLS CUI [1,4]
- C3840932
Descripción
pharmacogenetic tests, genetics type
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0017399
- UMLS CUI [1,3]
- C0332307
Similar models
Pharmacogenetic Research
- StudyEvent: ODM
C0021430 (UMLS CUI-2)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0021430 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C3840932 (UMLS CUI [1,4])
C0332307 (UMLS CUI [1,2])
C0021430 (UMLS CUI-2)
C2349954 (UMLS CUI-3)
C0021430 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C1948029 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C3840932 (UMLS CUI [1,4])
C0017399 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])